Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Ebola Outbreak Forces DR Congo World Cup Squad into Extended Isolation Raising Logistics and Cost Concerns Kevin Warsh Poised to Enter Fed Amid Internal Debate Over Interest Rate Cuts Jeremy Granthams Investment Mantra Patience and Value in Volatile Markets NATO Defense Spending Surge and US Troop Deployment to Poland Signal Geopolitical Shift Everlane Founder Michael Preysman Announces New Venture After Shein Acquisition Oklo Inc OKLO Q1 2026 Earnings EPS Surpasses Estimates Amid No Revenue Reported Diageo DEO Q1 2026 Earnings EPS Misses Estimates Amid Volume Pressures Stock Edges Higher Warby Parker WRBY Q1 2026 Earnings EPS Beat Drives Optimistic Start to Fiscal Year Valero Energy VLO Q1 2026 Earnings Strong EPS Beat Signals Resilience in Refining Margins SILC Q1 2026 Earnings Narrower Loss Than Expected Drives Stock Higher Morgan Stanley China A Share Fund CAF Edges Higher Amidst Cautious Market Sentiment Fiverr FVRR Holds Steady Near Key Support as Stock Trades Flat Cognition Therapeutics CGTX Slides 159 as Biotech Sector Headwinds Persist EDU Shows Modest Uptick Amid Sector Consolidation Support and Resistance Levels in Focus Wordle 1800 Marks Milestone for NYTs Digital Subscription Strategy Endurance Technologies IPO Opens Company Aims to Raise Rs 1162 Crore Japans Food Industry Faces Shrinking Market and Geopolitical Headwinds Mortgage Rate Survey Reveals Shakeup in Lender Rankings After Memorial Day Weekend MOLN Q4 2025 Earnings Positive EPS Surprise Highlights Cost Discipline Amid Clinical Progress ATAT Q1 2026 Earnings EPS Surges Past Estimates Stock Declines Despite Strong Beat Exicure XCUR Q2 2022 Earnings WiderThanExpected Loss Fails to Deter Investors Nicolet Bankshares Q1 2026 Earnings Earnings Miss Estimates by Wide Margin Amid Challenging Environment VerifyMe Q4 2025 Earnings EPS Misses Estimates as Revenue Details Remain Unavailable Corbus Pharmaceuticals Q1 2026 Earnings SmallerThanExpected Loss Amid Pipeline Progress